{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:57:09Z","timestamp":1790632629299,"version":"4.1.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.exer.2019.107788","type":"journal-article","created":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T01:47:10Z","timestamp":1567216030000},"page":"107788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Aldosterone as a mediator of severity in retinal vascular disease: Evidence and potential mechanisms"],"prefix":"10.1016","volume":"188","author":[{"given":"Michael J.","family":"Allingham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyatham S.","family":"Mettu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott W.","family":"Cousins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2019.107788_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1167\/tvst.6.2.7","article-title":"A quantitative approach to predict differential effects of anti-VEGF treatment on diffuse and focal leakage in patients with diabetic macular edema: a pilot study","volume":"6","author":"Allingham","year":"2017","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.exer.2019.107788_bib2","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1167\/iovs.17-23073","article-title":"Aldosterone exposure causes increased retinal edema and severe retinopathy following laser-induced retinal vein occlusion in mice","volume":"59","author":"Allingham","year":"2018","journal-title":"Investig. Opthalmology Vis. Sci."},{"key":"10.1016\/j.exer.2019.107788_bib3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.3037703","article-title":"Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor","volume":"237","author":"Arriza","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.exer.2019.107788_bib4","article-title":"CONN syndrome presenting as central retinal vein occlusion","volume":"1","author":"Atik","year":"2017","journal-title":"Retin. Cases Brief Rep."},{"key":"10.1016\/j.exer.2019.107788_bib5","first-page":"1450","article-title":"Renin-containing M\u00fcller cells of the retina display endocrine features","volume":"36","author":"Berka","year":"1995","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107788_bib6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/ajh\/hpy158","article-title":"Vascular mineralocorticoid receptor: evolutionary mediator of wound healing turned harmful by our modern lifestyle","volume":"32","author":"Biwer","year":"2019","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.exer.2019.107788_bib7","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1097\/IAE.0b013e318297a07a","article-title":"Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy","volume":"33","author":"Bousquet","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.exer.2019.107788_bib8","doi-asserted-by":"crossref","first-page":"107754","DOI":"10.1016\/j.exer.2019.107754","article-title":"Mineralocorticoid antagonists in the treatment of central serous chorioetinopathy: review of the pre-clinical and clinical evidence","author":"Bousquet","year":"2019","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2019.107788_bib9","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.ophtha.2012.01.042","article-title":"Vascular endothelial growth factor Trap-Eye for macular edema secondary to central retinal vein occlusion: six-month results of the phase 3 COPERNICUS study","volume":"119","author":"Boyer","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2019.107788_bib10","first-page":"1","article-title":"Three-Year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema","author":"Boyer","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2019.107788_bib11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11906-011-0182-2","article-title":"The role of aldosterone in the metabolic syndrome","volume":"13","author":"Briet","year":"2011","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.exer.2019.107788_bib12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/cne.20413","article-title":"Photoreceptor synapses degenerate early in experimental choroidal neovascularization","volume":"483","author":"Caicedo","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.exer.2019.107788_bib13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.exer.2005.01.013","article-title":"Blood-derived macrophages infiltrate the retina and activate Muller glial cells under experimental choroidal neovascularization","volume":"81","author":"Caicedo","year":"2005","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2019.107788_bib14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ophtha.2013.08.038","article-title":"Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study","volume":"121","author":"Campochiaro","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2019.107788_bib15","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.ophtha.2010.12.028","article-title":"Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema","volume":"118","author":"Campochiaro","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2019.107788_bib16","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1161\/CIRCRESAHA.108.174235","article-title":"Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion","volume":"102","author":"Caprio","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.exer.2019.107788_bib17","first-page":"318","article-title":"Resistant hypertension and aldosterone: an update","volume":"28","author":"Clark","year":"2012","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.exer.2019.107788_bib18","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1161\/HYPERTENSIONAHA.111.188136","article-title":"Neovascularization is attenuated with aldosterone synthase inhibition in rats with retinopathy","volume":"59","author":"Deliyanti","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.exer.2019.107788_bib19","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.111.188136","article-title":"Neovascularization is attenuated with aldosterone synthase inhibition in rats with retinopathy","volume":"59","author":"Deliyanti","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.exer.2019.107788_bib20","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.ophtha.2011.02.018","article-title":"The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema","volume":"118","author":"Do","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2019.107788_bib21","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1167\/iovs.16-20474","article-title":"Microglia activation and recruitment of circulating macrophages during ischemic experimental branch retinal vein occlusion","volume":"58","author":"Ebneter","year":"2017","journal-title":"Investig. Opthalmology Vis. Sci."},{"key":"10.1016\/j.exer.2019.107788_bib22","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ophtha.2010.02.031","article-title":"Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema","volume":"117","author":"Elman","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2019.107788_bib23","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/archopht.1982.01030040110020","article-title":"Histopathologic study of nine branch retinal vein occlusions","volume":"100","author":"Frangieh","year":"1982","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107788_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18051032","article-title":"Aldosterone and mineralocorticoid receptors-physiology and pathophysiology","volume":"18","author":"Funder","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2019.107788_bib25","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1126\/science.2845584","article-title":"Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated","volume":"242","author":"Funder","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.exer.2019.107788_bib26","doi-asserted-by":"crossref","first-page":"E342","DOI":"10.1152\/ajpendo.00355.2004","article-title":"Is aldosterone synthesized within the rat brain?","volume":"288","author":"Gomez-Sanchez","year":"2005","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.exer.2019.107788_bib27","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3109\/07435809809032689","article-title":"Aldosterone in obesity","volume":"24","author":"Goodfriend","year":"1998","journal-title":"Endocr. Res."},{"key":"10.1016\/j.exer.2019.107788_bib28","first-page":"27","article-title":"Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases","volume":"1","author":"Green","year":"1981","journal-title":"Retina"},{"key":"10.1016\/j.exer.2019.107788_bib29","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41598-017-00461-9","article-title":"Salt-dependent blood pressure in human aldosterone synthase-transgenic mice","volume":"7","author":"Gu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2019.107788_bib30","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ophtha.2003.09.024","article-title":"Risk factors for central serous chorioretinopathy: a case-control study","volume":"111","author":"Haimovici","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2019.107788_bib31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1530\/EJE-11-1013","article-title":"Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies","volume":"167","author":"Hannemann","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.exer.2019.107788_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2014.04.001","article-title":"Ocular vascular occlusive disorders: natural history of visual outcome","volume":"41","author":"Hayreh","year":"2014","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2019.107788_bib33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0002-9394(00)00709-1","article-title":"Systemic diseases associated with various types of retinal vein occlusion","volume":"131","author":"Hayreh","year":"2001","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107788_bib34","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.ophtha.2011.12.005","article-title":"Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial","volume":"119","author":"Heier","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2019.107788_bib35","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.ophtha.2014.01.027","article-title":"Intravitreal aflibercept injection for macular edema due to central retinal vein occlusion: two-year results from the COPERNICUS study","volume":"121","author":"Heier","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2019.107788_bib36","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s00417-014-2780-6","article-title":"Spironolactone in the treatment of central serous chorioretinopathy \u2013 a case series","volume":"252","author":"Herold","year":"2014","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107788_bib37","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/archophthalmol.2012.1043","article-title":"Long-term effects of ranibizumab on diabetic retinopathy severity and progression","volume":"130","author":"Ip","year":"2012","journal-title":"Arch. Ophthalmol. (Chicago, Ill. 1960)"},{"key":"10.1016\/j.exer.2019.107788_bib38","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1161\/CIRCRESAHA.115.308269","article-title":"Endothelial mineralocorticoid receptor mediates diet-induced aortic stiffness in females","volume":"118","author":"Jia","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.exer.2019.107788_bib39","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009890","article-title":"Renin\u2010angiotensin\u2010aldosterone system, glucose metabolism and incident type 2 diabetes mellitus: MESA","volume":"7","author":"Joseph","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.exer.2019.107788_bib40","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/09286580701396720","article-title":"Overview of epidemiologic studies of diabetic retinopathy","volume":"14","author":"Klein","year":"2007","journal-title":"Ophthalmic Epidemiol."},{"key":"10.1016\/j.exer.2019.107788_bib41","first-page":"1","article-title":"Intravitreal aflibercept for diabetic macular edema","author":"Korobelnik","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2019.107788_bib42","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1007\/s00417-015-3094-z","article-title":"Abundance of infiltrating CD163+ cells in the retina of postmortem eyes with dry and neovascular age-related macular degeneration","volume":"253","author":"Lad","year":"2015","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107788_bib43","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ajo.2014.05.014","article-title":"Anti-vegf treatment patterns for neovascular age-related macular degeneration among medicare beneficiaries","volume":"158","author":"Lad","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107788_bib44","doi-asserted-by":"crossref","first-page":"e0145946","DOI":"10.1371\/journal.pone.0145946","article-title":"Aldosterone induces renal fibrosis and inflammatory M1-macrophage subtype via mineralocorticoid receptor in rats","volume":"11","author":"Mart\u00edn-Fern\u00e1ndez","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2019.107788_bib45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fendo.2015.00153","article-title":"Mineralocorticoid receptors in the pathophysiology of vascular inflammation and atherosclerosis","volume":"6","author":"Moss","year":"2015","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.exer.2019.107788_bib46","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/01.HYP.0000226054.53527.bb","article-title":"Molecular mechanism of the inhibitory effect of aldosterone on endothelial NO synthase activity","volume":"48","author":"Nagata","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.exer.2019.107788_bib47","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ophtha.2011.12.039","article-title":"Ranibizumab for diabetic macular edema","volume":"119","author":"Nguyen","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2019.107788_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.240","article-title":"Aldosterone: a mediator of retinal ganglion cell death and the potential role in the pathogenesis in normal-tension glaucoma","volume":"4","author":"Nitta","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.exer.2019.107788_bib49","doi-asserted-by":"crossref","unstructured":"Okada, Y., Yamanaka, I., Sakamoto, T., Hata, Y., Sassa, Y., Yoshikawa, H., Fujisawa, K., Ishibashi, T., Inomata, H., n.d. Increased expression of angiotensin-converting enzyme in retinas of diabetic rats. Jpn. J. Ophthalmol. 45, 585\u2013591.","DOI":"10.1016\/S0021-5155(01)00412-9"},{"key":"10.1016\/j.exer.2019.107788_bib50","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0161-6420(95)30848-2","article-title":"A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. The Central Vein Occlusion Study Group N report","volume":"102","author":"Panretinal","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2019.107788_bib51","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3109\/08820538.2011.570845","article-title":"Review of ranibizumab trials for neovascular age-related macular degeneration","volume":"26","author":"Patel","year":"2011","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107788_bib52","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.ophtha.2014.11.018","article-title":"Long-Term outcomes in eyes receiving fixed-interval dosing of anti\u2013vascular endothelial growth factor Agents for wet age-related macular degeneration","volume":"122","author":"Peden","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2019.107788_bib53","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ajo.2008.03.025","article-title":"Fluocinolone acetonide sustained drug delivery device for chronic central retinal vein occlusion: 12-month results","volume":"146","author":"Ramchandran","year":"2008","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107788_bib54","doi-asserted-by":"crossref","first-page":"e108508","DOI":"10.1371\/journal.pone.0108508","article-title":"Chemokine mediated monocyte trafficking into the retina: role of inflammation in alteration of the blood-retinal barrier in diabetic retinopathy","volume":"9","author":"Rangasamy","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2019.107788_bib55","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/glia.22477","article-title":"New functions of M\u00fcller cells","volume":"61","author":"Reichenbach","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.exer.2019.107788_bib56","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00417-006-0516-y","article-title":"M\u00fcller cells as players in retinal degeneration and edema","volume":"245","author":"Reichenbach","year":"2007","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107788_bib57","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/archophthalmol.2009.234","article-title":"The standard care vs corticosteroid for retinal vein occlusion (SCORE) study report 5","volume":"127","author":"Retinal","year":"2009","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107788_bib58","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1056\/NEJM200002103420603","volume":"342","author":"Retinopathy and Nephropathy in Patients with Type 1 Diabetes Four Years after a Trial of Intensive Therapy","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exer.2019.107788_bib59","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0002-9394(14)71345-5","volume":"116","author":"Risk factors for branch retinal vein occlusion The Eye Disease Case-control Study Group","year":"1993","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107788_bib60","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archopht.1996.01100130537006","volume":"114","author":"Risk factors for central retinal vein occlusion The Eye Disease Case-Control Study Group","year":"1996","journal-title":"Arch. Ophthalmol. (Chicago, Ill. 1960)"},{"key":"10.1016\/j.exer.2019.107788_bib61","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1242\/dmm.009597","article-title":"Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals","volume":"5","author":"Robinson","year":"2012","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.exer.2019.107788_bib62","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ophtha.2009.07.017","article-title":"The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia","volume":"117","author":"Rogers","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2019.107788_bib63","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.2337\/db08-0254","article-title":"(Pro)renin receptor-mediated signal transduction and tissue renin-angiotensin system contribute to diabetes-induced retinal inflammation","volume":"58","author":"Satofuka","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.exer.2019.107788_bib64","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1093\/eurheartj\/eht095","article-title":"Endothelial mineralocorticoid receptor activation mediates endothelial dysfunction in diet-induced obesity","volume":"34","author":"Sch\u00e4fer","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.exer.2019.107788_bib65","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1001\/jama.2017.4568","article-title":"Effect of bevacizumab vs aflibercept on visual acuity among patients with macular edema due to central retinal vein occlusion","volume":"317","author":"Scott","year":"2017","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.exer.2019.107788_bib66","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.ophtha.2015.12.002","article-title":"Macular morphology and visual acuity in the second year of the comparison of age-related macular degeneration treatments trials","volume":"123","author":"Sharma","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2019.107788_bib67","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(08)61411-7","article-title":"Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial","volume":"372","author":"Sjolie","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.exer.2019.107788_bib68","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s004170050028","article-title":"Continued progression of retinopathy despite spontaneous recovery to normoglycemia in a long-term study of streptozotocin-induced diabetes in rats","volume":"238","author":"Su","year":"2000","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107788_bib69","article-title":"Elevated plasma aldosterone levels are associated with a reduction in retinal ganglion cell survival","volume":"19","author":"Takasago","year":"2018","journal-title":"J. Renin-Angiotensin-Aldosterone Syst. JRAAS"},{"key":"10.1016\/j.exer.2019.107788_bib70","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1152\/ajpendo.00100.2011","article-title":"Extra-adrenal glucocorticoids and mineralocorticoids: evidence for local synthesis, regulation, and function","volume":"301","author":"Taves","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.exer.2019.107788_bib71","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","volume":"317","author":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 UK Prospective Diabetes Study Group","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.exer.2019.107788_bib72","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S2213-8587(14)70256-6","article-title":"Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis","volume":"3","author":"Wang","year":"2015","journal-title":"lancet. Diabetes Endocrinol."},{"key":"10.1016\/j.exer.2019.107788_bib73","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.ophtha.2016.02.022","article-title":"Diabetic retinopathy clinical research network, 2016. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema","volume":"123","author":"Wells","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2019.107788_bib74","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1470320314549791","article-title":"Expression of classical components of the renin-angiotensin system in the human eye","volume":"16","author":"White","year":"2015","journal-title":"J. Renin-Angiotensin-Aldosterone Syst. JRAAS"},{"key":"10.1016\/j.exer.2019.107788_bib75","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.biocel.2005.08.002","article-title":"Angiotensin and diabetic retinopathy","volume":"38","author":"Wilkinson-Berka","year":"2006","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.exer.2019.107788_bib76","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.peptides.2012.04.008","article-title":"The retinal renin-angiotensin system: roles of angiotensin II and aldosterone","volume":"36","author":"Wilkinson-Berka","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.exer.2019.107788_bib77","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCRESAHA.108.176008","article-title":"Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology","volume":"104","author":"Wilkinson-Berka","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.exer.2019.107788_bib78","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCRESAHA.108.176008","article-title":"Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology","volume":"104","author":"Wilkinson-Berka","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.exer.2019.107788_bib79","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/IAE.0000000000000277","article-title":"Progressive retinal nonperfusion IN ischemic central retinal vein occlusion","volume":"35","author":"Wykoff","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.exer.2019.107788_bib80","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.exer.2019.107788_bib81","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/archophthalmol.2007.65","article-title":"Microglial activation in human diabetic retinopathy","volume":"126","author":"Zeng","year":"2008","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107788_bib82","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI61427","article-title":"Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy","volume":"122","author":"Zhao","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.exer.2019.107788_bib83","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41467-018-08125-6","article-title":"Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration","volume":"10","author":"Zhao","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.exer.2019.107788_bib84","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1096\/fj.09-154344","article-title":"The neuroretina is a novel mineralocorticoid target: aldosterone up-regulates ion and water channels in M\u00fcller glial cells","volume":"24","author":"Zhao","year":"2010","journal-title":"FASEB J."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483519304191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483519304191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:00:58Z","timestamp":1757998858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483519304191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":84,"alternative-id":["S0014483519304191"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2019.107788","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aldosterone as a mediator of severity in retinal vascular disease: Evidence and potential mechanisms","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2019.107788","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107788"}}